Page 18 - Managing Science Editor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Managing science editor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Managing Science Editor Today - Breaking & Trending Today

Cooling Vest Marks Fourth Anniversary During MS Awareness Month


4.8
(20)
ThermApparel is observing Multiple Sclerosis Awareness Month by  celebrating the fourth anniversary of its cooling vest, designed for multiple sclerosis (MS) patients and others with extreme sensitivity to heat.
“Our mission was to provide customers with a state-of-the-art cooling vest that looks and feels great, and is extremely fashionable,” Kurtis Kracke, founder and CEO of ThermApparel, said in a press release.
Although a large percentage of patients with MS experience a worsening in symptoms or flare-ups when exposed to high temperatures, there were no MS-specific cooling garments on the U.S. market until ThermApparel started manufacturing its UnderCool vests four years ago. ....

Kurtis Kracke , University Of Lisbon , Biomedical Sciences , Multiple Sclerosis Awareness Month , Universidade Nova De Lisboa , Molecular Biology , Managing Science Editor , பல்கலைக்கழகம் ஆஃப் லிஸ்பன் , உயிர் மருத்துவ அறிவியல் , பல ஸ்க்லரோசிஸ் விழிப்புணர்வு மாதம் , யுனிவர்சிடேட் நோவா டி லிஸ்போவா , மூலக்கூறு உயிரியல் , நிர்வகித்தல் அறிவியல் ஆசிரியர் ,

Retinal Cell Loss Worse with Interferon-beta vs. Other DMTs, Study Finds


In MS, the immune system targets nerve cell axons that transmit signals from the brain to other parts of the body, leading to inflammation and nerve degeneration.
Degeneration in certain nerve layers in the back of the eye appear to correlate with greater brain damage in MS. Thus, the neuroprotective effects of current MS therapies can be examined through their impact on these layers.
In this study, researchers at the University of Sydney, in Australia, examined the impact of several approved DMTs on retinal ganglion cell loss in MS patients.
To assess retinal nerve cell degeneration, they compared the thinning of three retina layers the global peripapillary retinal nerve fiber layer, the temporal retinal nerve fiber layer, and the ganglion cell inner plexiform layer over time in patients taking distinct DMTs. ....

New South Wales , Neuroimmunology Neuroinflammation , Faisha Abdullah , University Of Lisbon , Weill Cornell Medical College , Biomedical Sciences , University Of Sydney , University Of Houston , Retinal Ganglion Cell Loss , Neurology Neuroimmunology , Molecular Biology , Universidade Nova De Lisboa , Managing Science Editor , புதியது தெற்கு வேல்ஸ் , ஆயிஷா அப்துல்லா , பல்கலைக்கழகம் ஆஃப் லிஸ்பன் , வெயில் கார்னெல் மருத்துவ கல்லூரி , உயிர் மருத்துவ அறிவியல் , பல்கலைக்கழகம் ஆஃப் சிட்னி , பல்கலைக்கழகம் ஆஃப் ஹூஸ்டன் , மூலக்கூறு உயிரியல் , யுனிவர்சிடேட் நோவா டி லிஸ்போவா , நிர்வகித்தல் அறிவியல் ஆசிரியர் ,

Ampyra Aids More Than Walking in MS, But Side Effects May Be of Concern - Multiple Sclerosis News Today